Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory B Cell Subset Induction (Breg Induction)
- Target
- Breg Induction
- Molecular classification
- Cellular Differentiation, Cytokine Signaling, B Cell Receptor Signaling
01
Overview
Regulatory B cells (Bregs) are a specialized subset of B lymphocytes with immunosuppressive functions, primarily through the production of anti-inflammatory cytokines such as interleukin-10 (IL-10) and granzyme B. The induction of these regulatory subsets is a dynamic process influenced by various microenvironmental factors, cytokines (BAFF, IL-21, IL-5/IL-4), and cell signaling pathways. Induction leads to suppression of effector T cell responses, downregulation of inflammation and autoimmunity, and maintenance of immune tolerance. The ability to induce or expand specific regulatory B cell populations has therapeutic implications for autoimmune diseases, transplantation tolerance, allergy control, and cancer immunotherapy modulation.
- Other names
- Breg DifferentiationIL-10 Producing B Cell InductionRegulatory B Cell Development
02
Mechanism of action
Modulation of B cell differentiation to promote regulatory phenotypes; Enhancement of IL-10 production and secretion; Induction of granzyme B secretion
03
Biological functions
Immune regulationInflammation suppressionAutoimmunity preventionTolerance induction
04
Disease associations
Autoimmune diseasesCancerTransplantation rejectionAllergyInflammatory diseases
05
Safety considerations
Potential for immune suppression leading to increased risk of infectionUnintended consequences of broad immune modulationTumor promotion in certain contexts
06
Biomarkers
CD19CD1dCD5CD24CD38IL-10Granzyme B
Beyond the preview
Go deeper on Regulatory B Cell Subset Induction (Breg Induction).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regulatory B Cell Subset Induction (Breg Induction).